focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 222.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.446%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 222.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: J Smart boosts revenue, Tertiary starts drilling

Tue, 16th Apr 2024 21:57

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value was 39.7 pence per share at February 29, down from 45.3 pence at February 28, 2023. Chair says: "In a year when the FTSE AIM All Share Index declined by 14%, your company made a loss of GBP1.75 million with net assets down by 19%" and that this year's results "can only be described as disappointing". Declares 55.0p dividend for the year to February 29, unchanged from the year before. Says it now has "the critical mass we have been seeking for a long time", and that it is currently seeking alternative plans to manage its rump portfolio once its primary assets have been realised.

----------

Petra Diamonds Ltd - Bermuda-based diamond mining group - Says revenue for the third quarter of financial 2024 totalled USD66 million, down from USD90 million in the second quarter. Says the decrease was due to lower production and the timing of receipts from Tender 5. Says this fifth tender cycle yielded USD49 million from the sale of 362,132 carats at an average price of USD136 per carat. This compares with USD48 million from 428,860 carats at USD112 per carat in the fourth tender cycle. Says production for the quarter was consistent with the preceding three months and in line with expectations. Total tonnes treated decreased 1.5% to 2.9 million tonnes from 3.0 million tonnes.

----------

J Smart & Co (Contractors) PLC - Edinburgh-based construction contractor - Pretax profit for the six months to January 31 falls 21% to GBP205,000 from GBP260,000 the year before. Revenue however rises 54% to GBP8.6 million from GBP5.6 million. Company declares 0.96p per share interim dividend, unchanged year-on-year. Cost of sales rises to GBP6.4 million from GBP2.1 million. Company says construction material prices "are still rising, which continues to affect the viability of all types of potential projects". Says there has been a "slight improvement" on limited reservations compared to in late 2023, but continuing economic issues are still affecting consumer sentiment. Says lettings remain "robust" but that in the year to July 31 "there will definitely be profit erosion due to lack of external contracts, the lack of recovery of overhead costs, the continued increase in material costs, prolonged programmes due to utility infrastructure and statutory authority delays and the cost of holding private housing stock".

----------

Tertiary Minerals PLC - mineral development company focused on deposits in the US, Zambia and Northern Europe - Announces that drilling is now underway at the Konkola West Copper Project in Zambia. The project "is targeting projected deep down-dip and along-strike extensions of the contiguous Lubambe-Mingomba-Konkola copper deposits to the east of the licence and which extend north into the Musoshi mining complex in the Democratic Republic of the Congo". The long continuous zone of mineralisation is 15 kilometres total and contained a pre-mining endowment of over 775 million tonnes of copper graded at between 2% and 3%.

----------

PureTech Health PLC - London-based biotherapeutics company - Completes enrolment in the Elevate IPF Phase 2b clinical trial, which will evaluate LYT-100 or deupirfenidone in patients with idiopathic pulmonary fibrosis or IPF. Says LYT-100 is a deuterated form of pirfenidone, one of the two standard-of-care treatments approved to treat IPF. The randomised double-blind trial will measure as primary endpoint the rate of decline in forced vital capacity for the combined LYT-100 arms versus the placebo group over 26 weeks. Says other key endpoints will include tolerability measures, biomarkers and patient-reported outcomes. Expects topline results in the fourth quarter of 2024.

----------

DP Poland PLC - London-based operator of Domino's pizza stores and restaurants in Poland and Croatia - Raises gross GBP1 million pursuant to oversubscribed retail offer, with 10.1 million shares to be issued as a result. Says it has raised around GBP20.5 million in total from subscription, placing and retail offer combined. Fundraise was announced in late March, with placing price of 9.92p per share. This included a GBP11 million investment from Domino's Pizza Group PLC.

----------

Golden Metal Resources PLC - Nevada-focused metals exploration company - Says ground magnetic survey has detected significant anomalies at its Garfield project in Nevada's Walker Lane Mineral Belt. Says two magnetic anomalies were detected within the 'High-Grade' zone, and another was located in the southwestern part of the 'Power-Line' zone. Says it is "very encouraged" by the results, and has commissioned a ground magnetic geophysics survey across some of the main target areas at Pilot Mountain. Results are currently being processed. Adds that drilling preparations for Pilot Mountain are "well underway" and expects to receive permits "imminently". Chief Executive Officer Oliver Friesen says 2024 "is shaping up to be a very exciting year for Golden Metal", which is "positioned perfectly to address" the increasing demand for "important metals such as tungsten".

----------

By Emma Curzon, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
21 Jun 2023 12:36

PureTech Health launches next stage of anxiety disorder drug trial

(Alliance News) - PureTech Health PLC on Wednesday said that it has started the next stage of trials for LYT-300, in order to test whether the therapy could be used to treat anxiety disorders.

Read more
7 Jun 2023 13:57

PureTech Health's Akili launches ADHD immersive treatment in US

(Alliance News) - PureTech Health PLC on Wednesday said its founded entity, Akili Inc, released an attention deficit hyperactivity disorder treatment for adult patients.

Read more
9 May 2023 11:13

PureTech's Vedanta Biosciences receives US FDA fast track designation

(Alliance News) - PureTech Health PLC on Tuesday said its founded entity, Vedanta Biosciences, has been granted fast track designation from the US Food & Drug Administration for its bacterial consortium candidate, VE303, for the prevention of recurrent Clostridioides difficile infection.

Read more
4 May 2023 11:46

IN BRIEF: PureTech notes Akili's results for EndeavorRx ADHD trial

PureTech Health PLC - Boston-based biotechnology company - Says its founded entity, Akili, announced clinical trial for video game-based therapy, EndeavorRx, showed improvement in attention and quality of life for people with attention deficit hyperactivity disorder. Notes attention improved in more than 80% of adults with ADHD, while over a third of participants "no longer exhibited an attention deficit following treatment."

Read more
2 May 2023 09:34

LONDON BROKER RATINGS: HSBC raises Rightmove to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
28 Apr 2023 11:13

PureTech Health yearly loss widens but remains optimistic

(Alliance News) - PureTech Health PLC on Friday said its loss widened in 2022 and revenue declined, though it hailed an "exceptional" year and expects further success in 2023.

Read more
25 Apr 2023 18:33

TRADING UPDATES: Eagle Eye signs new John Lewis deal, Neometals update

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News:

Read more
21 Apr 2023 15:51

UK earnings, trading statements calendar - next 7 days

Monday 24 April 
Brighton Pier Group PLCFull Year Results
CentralNic Group PLCTrading Statement
Checkit PLCFull Year Results
Egdon Resources PLCHalf Year Results
Keystone Law Group PLCFull Year Results
Lok'n Store Group PLCHalf Year Results
Novacyt SAFull Year Results
Tuesday 25 April 
AB Dynamics PLCHalf Year Results
Anglo American PLCTrading Statement
Associated British Foods PLCHalf Year Results
Avacta Group PLCFull Year Results
Banco Santander SAQ1 Results
Card Factory PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Corero Network Security PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
hVIVO PLCFull Year Results
IWG PLCTrading Statement
Jadestone Energy PLCFull Year Results
Loungers PLCTrading Statement
Next Fifteen Communications Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Oxford BioMedica PLCFull Year Results
Quilter PLCTrading Statement
Resolute Mining LtdTrading Statement
Round Hill Music Royalty Fund LtdFull Year Results
RWS Holdings PLCTrading Statement
Travis Perkins PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
Whitbread PLCFull Year Results
Wednesday 26 April 
1Spatial PLCFull Year Results
Biome Technologies PLCFull Year Results
Bunzl PLCQ1 Results
C4X Discovery Holdings PLCHalf Year Results
CRH PLCTrading Statement
Ecora Resources PLCTrading Statement
Frenkel Topping Group PLCFull Year Results
Fresnillo PLCTrading Statement
Gem Diamonds LtdTrading Statement
Glencore PLCTrading Statement
GSK PLCQ1 Results
Home REIT PLCHalf Year Results
Learning Technologies Group PLCFull Year Results
Man Group PLCTrading Statement
Pennant International Group PLCFull Year Results
RBG Holdings PLCFull Year Results
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Skillcast Group PLCFull Year Results
Smith & Nephew PLCTrading Statement
Standard Chartered PLCQ1 Results
Trifast PLCTrading Statement
Warpaint London PLCFull Year Results
Thursday 27 April 
AstraZeneca PLCTrading Statement
Barclays PLCQ1 Results
Brave Bison Group PLCFull Year Results
Capricorn Energy PLCFull Year Results
GCP Infrastructure Investments LtdTrading Statement
Howden Joinery Group PLCTrading Statement
Inchcape PLCTrading Statement
Indivior PLCQ1 Results
Inspecs Group PLCFull Year Results
J Sainsbury PLCFull Year Results
Lancashire Holdings LtdTrading Statement
Literacy Capital PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Molten Ventures PLCTrading Statement
Petrofac LtdFull Year Results
PPHE Hotel Group LtdTrading Statement
Schroders PLCTrading Statement
Spectris PLCQ1 Results
St James's Place PLCTrading Statement
Synairgen PLCFull Year Results
Taylor Wimpey PLCTrading Statement
Unilever PLCTrading Statement
WPP PLCTrading Statement
Friday 28 April 
Alphawave IP Group PLCFull Year Results
Alphawave IP Group PLCTrading Statement
Argo Blockchain PLCfull Year Results
Computacenter PLCTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Industrials REIT LtdTrading Statement
James Fisher & Sons PLCFull Year Results
Kingspan Group PLCTrading Statement
LMS Capital PLCTrading Statement
Morgan Advanced Materials PLCFull Year Results
NatWest Group PLCQ1 Results
Pearson PLCTrading Statement
PureTech Health PLCFull Year Results
Record PLCTrading Statement
Renishaw PLCTrading Statement
Rotork PLCQ1 Results
Smurfit Kappa Group PLCTrading Statement
Westminster Group PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
17 Apr 2023 09:01

PureTech Health's Vedanta Biosciences boasts "promising" results

(Alliance News) - PureTech Health PLC on Monday said that its founded entity, Vedanta Biosciences, has seen positive results for its lead programme, VE303.

Read more
23 Mar 2023 12:23

LONDON MARKET MIDDAY: Bank of England lifts rates by 25 basis points

(Alliance News) - Stock prices in London were largely lower at midday on Thursday, raised UK interest rates by 25 basis points on Thursday, as widely expected, and indicated that further tightening in monetary policy may be required.

Read more
23 Mar 2023 10:11

PureTech Health says Royalty Pharma acquires Karuna Royalties

(Alliance News) - PureTech Health PLC on Thursday said Royalty Pharma PLC has acquired an interest in PureTech's royalty in Karuna Therapeutics Inc's KarXT schizophrenia treatment.

Read more
23 Mar 2023 07:24

US Royalty Pharma strikes deal with PureTech Health on KarXT royalties

(Sharecast News) - US-listed Royalty Pharma has acquired an interest in PureTech Health's royalty in Karuna Therapeutics' KarXT drug for up to $500m, with $100m in cash up front and up to $400m in additional payments contingent on the achievement of certain regulatory and commercial milestones.

Read more
20 Mar 2023 16:01

PureTech Health says Karuna KArXT trial receives positive results

(Alliance News) - PureTech Health PLC on Monday said its founded entity, Karuna Therapeutics Inc announced its phase 3 EMERGENT-3 trial of KarXT in Schizophrenia has met its primary endpoint.

Read more
28 Feb 2023 21:05

TRADING UPDATES: Eco Atlantic swings to loss; Curtis approves takeover

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
14 Feb 2023 13:27

IN BRIEF: PureTech Health to start trials for anxiety, depression drug

PureTech Health PLC - clinical-stage biotherapeutics company - Says it will advance LYT-300 for the potential treatment of anxiety disorders and post-partum depression. A placebo-controlled, phase 2a, proof-of-concept, social anxiety clinical trial is expected to begin in the first half of 2023. Results are expected by the end of the year. An open-label, phase 2a, proof-of-concept clinical trial in women with post-partum depression is expected to begin in the second half of 2023.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.